1 | chilena de obstetricia y | | | | | | | 3 | 0.55% |
2 | de obstetricia y ginecología | | | | | | | 2 | 0.36% |
3 | cÓdigo de conducta para | | | | | | | 2 | 0.36% |
4 | sociedad chilena de obstetricia | | | | | | | 2 | 0.36% |
5 | toggle navigation inicio home | | | | | | | 1 | 0.18% |
6 | oscar e riveracontreras julián | | | | | | | 1 | 0.18% |
7 | sangrado uterino anormal como | | | | | | | 1 | 0.18% |
8 | agudelo sangrado uterino anormal | | | | | | | 1 | 0.18% |
9 | s agudelo sangrado uterino | | | | | | | 1 | 0.18% |
10 | janer s agudelo sangrado | | | | | | | 1 | 0.18% |
11 | jaramilloaraujo janer s agudelo | | | | | | | 1 | 0.18% |
12 | h jiménezgiraldo walter e | | | | | | | 1 | 0.18% |
13 | julián h jiménezgiraldo walter | | | | | | | 1 | 0.18% |
14 | riveracontreras julián h jiménezgiraldo | | | | | | | 1 | 0.18% |
15 | e riveracontreras julián h | | | | | | | 1 | 0.18% |
16 | bacteriana ascendente revisión narrativa | | | | | | | 1 | 0.18% |
17 | ascendente revisión narrativa × | | | | | | | 1 | 0.18% |
18 | inicial de malignidades hematológicas | | | | | | | 1 | 0.18% |
19 | infección bacteriana ascendente revisión | | | | | | | 1 | 0.18% |
20 | por infección bacteriana ascendente | | | | | | | 1 | 0.18% |
21 | prematuro por infección bacteriana | | | | | | | 1 | 0.18% |
22 | embarazada propensa a parto | | | | | | | 1 | 0.18% |
23 | la embarazada propensa a | | | | | | | 1 | 0.18% |
24 | de la embarazada propensa | | | | | | | 1 | 0.18% |
25 | vaginal de la embarazada | | | | | | | 1 | 0.18% |
26 | inmunológico vaginal de la | | | | | | | 1 | 0.18% |
27 | perfil inmunológico vaginal de | | | | | | | 1 | 0.18% |
28 | enrique oyarzun microbiota y | | | | | | | 1 | 0.18% |
29 | presentación inicial de malignidades | | | | | | | 1 | 0.18% |
30 | sánchezprieto cristina llanezasuárez alejandro | | | | | | | 1 | 0.18% |
31 | de malignidades hematológicas × | | | | | | | 1 | 0.18% |
32 | estetrol en la anticoncepción | | | | | | | 1 | 0.18% |
33 | orizaola begoña angulo m | | | | | | | 1 | 0.18% |
34 | ana orizaola begoña angulo | | | | | | | 1 | 0.18% |
35 | lucía fernándezcalderón jesús garde | | | | | | | 1 | 0.18% |
36 | cases lucía fernándezcalderón jesús | | | | | | | 1 | 0.18% |
37 | clínicosclinical cases lucía fernándezcalderón | | | | | | | 1 | 0.18% |
38 | casos clínicosclinical cases lucía | | | | | | | 1 | 0.18% |
39 | una revisión integral × | | | | | | | 1 | 0.18% |
40 | anticoncepción una revisión integral | | | | | | | 1 | 0.18% |